PAD - Prescribing Advisory Database
Surrey
Prescribing Advisory Database

Guidelines : Asthma

Detail

Condition :
Asthma
Keywords :
respiratory, inhalers, LAMAs, SABAs, ICS, High dose inhaled corticosteroid safety card, steroid card, inhaled steroid safety card, high dose ICS card, asthmatics, BTS, duplicate inhaler prescribing, know your inhalers
BNF Codes :

Committee Recommendations

Date
Committee Name
Narrative
Traffic Light Status
08 May 2024
Surrey Heartlands Medicines Safety Committee (MSC)

Duplicate prescribing of inhalers that contain the same medicine is a commonly reported medicines safety incident when a patient’s inhalers are changed.  The “Know your inhalers” diagram shows practice staff the class of medicine in commonly prescribed inhalers and will help to identify if there is potential for a duplicate inhaler prescribing error.

 
N/A
02 November 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The updated Primary Care Asthma Management Guidelines were approved by the APC.

The use of High Dose Inhaled Corticosteroid (ICS) Safety Cards are recommended where appropriate. Patients on very high doses should also be issued with a Steroid Emergency Card. Refer to the Steroid Card resources for guidance.

Spacer devices are recommended for use with Metered Dose Inhalation (MDI) devices.

Branded prescribing of corticosteroid inhalers is recommended following the increase in the range of inhaler devices now available. Patients should be prescribed an inhaler that meets their individual needs - where there is more than one option available, the brand with the lowest acquisition cost is recommended.

Patient education videos and instruction leaflets on the correct use of their inhaler devices can be found on PAD - search for the device by BRAND or select the device from the list of Drugs on the right of the screen. The full list of available videos and leaflets can be found here https://surreyccg.res-systems.net/pad/PatientResources?conditionid=263

 
N/A

Documents

Type
Document
Review Date
Guidelines (Local)
January 2024
Guidelines (Local)
November 2018
Guidelines (Local)
November 2024
Guidelines (Local)
November 2024
Guidelines (National)
Safety Information
Safety Information
Safety Information
Education material (for healthcare personnel)
May 2027
Webpage

Supplementary documents (CCG specific documents)

No records returned.

Drugs

Below are listed drugs that are used to treat Asthma.